$0.29
+0.02 (+6.98%)
Open$0.27
Previous Close$0.27
Day High$0.29
Day Low$0.27
52W High$0.45
52W Low$0.24
Volume—
Avg Volume520.0K
Market Cap28.12M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
6 analysts
Price Target
+5,387.7% upside
Current
$0.29
$0.29
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 966.9K | 981.9K | 13.95M |
| Net Income | -4,607,807 | -4,211,034 | 2.16M |
| Profit Margin | -477.1% | -453.3% | 15.5% |
| EBITDA | -8,238,798 | -7,947,662 | 3.52M |
| Free Cash Flow | — | — | 2.06M |
| Rev Growth | -1.5% | -1.5% | +17.1% |
| Debt/Equity | 0.02 | 0.02 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |